DalsnaFinance

Cellectar plans phase 3 trial for WM treatment after BTKi

Markets Investing.com By Investing.com 01 Jun 2026 12:13 1 min read
Cellectar plans phase 3 trial for WM treatment after BTKi

Cellectar plans phase 3 trial for WM treatment after BTKi

Cellectar plans phase 3 trial for WM treatment after BTKi

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.